Document Detail

Balancing tissue and tumor formation in regenerative medicine.
MedLine Citation:
PMID:  22896673     Owner:  NLM     Status:  In-Data-Review    
A set of general principles can guide preclinical testing strategies for evaluating the tumorigenicity of regenerative medicine products.
Alexander M Bailey
Related Documents :
24789383 - Management of fishing of the broadband anchovy (anchoviella lepidentostole) (fowler, 19...
25262083 - Greenhouse gas emissions from the enteric fermentation and manure storage of dairy and ...
22195233 - Diagnosis and management of ampullary adenoma: the expanding role of endoscopy.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Science translational medicine     Volume:  4     ISSN:  1946-6242     ISO Abbreviation:  Sci Transl Med     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-08-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101505086     Medline TA:  Sci Transl Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  147fs28     Citation Subset:  IM    
Office of Cellular, Tissue, and Gene Therapies, Center for Biologics Evaluation and Research, FDA, Rockville, MD 20852, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Dietary cholesterol increases paraoxonase 1 enzyme activity.
Next Document:  Brain superhighways.